Cargando…
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
Traditional cellular and live-virus methods for detection of SARS-CoV-2 neutralizing antibodies (nAbs) are labor- and time-intensive, and thus not suited for routine use in the clinical lab to predict vaccine efficacy and natural immune protection. Here, we report the development and validation of a...
Autores principales: | Cheedarla, Narayanaiah, Verkerke, Hans P., Potlapalli, Sindhu, McLendon, Kaleb Benjamin, Patel, Anamika, Frank, Filipp, O’Sick, William Henry, Cheedarla, Suneethamma, Baugh, Tyler Jon, Damhorst, Gregory L., Wu, Huixia, Graciaa, Daniel, Hudaib, Fuad, Alter, David N., Bryksin, Janetta, Ortlund, Eric A., Guarner, Jeanette, Auld, Sara, Shah, Sarita, Lam, Wilbur, Mattoon, Dawn, Johnson, Joseph M., Wilson, David H., Dhodapkar, Madhav V., Stowell, Sean R., Neish, Andrew S., Roback, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641509/ https://www.ncbi.nlm.nih.gov/pubmed/37965140 http://dx.doi.org/10.1016/j.isci.2023.108256 |
Ejemplares similares
-
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2022) -
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022) -
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023) -
COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
por: Govindaraj, Sakthivel, et al.
Publicado: (2023) -
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
por: Kumar, Sanjeev, et al.
Publicado: (2022)